uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
First-line and intensified treatment with glucose lowering drugs in the Swedish type 2 diabetes population
Karolinska Inst, Stockholm, Sweden..
AstraZeneca, Sodertalje, Sweden..
Karolinska Inst, Stockholm, Sweden..
Statisticon, Uppsala, Sweden..
Show others and affiliations
2015 (English)In: Diabetologia, ISSN 0012-186X, E-ISSN 1432-0428, Vol. 58, no Suppl. 1, S181-S181 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2015. Vol. 58, no Suppl. 1, S181-S181 p.
National Category
Endocrinology and Diabetes
URN: urn:nbn:se:uu:diva-264909ISI: 000359820901051OAI: oai:DiVA.org:uu-264909DiVA: diva2:867178
51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SEP 14-18, 2015, Stockholm, SWEDEN

Meeting Abstract: 361

Available from: 2015-11-04 Created: 2015-10-19 Last updated: 2015-11-04Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Medical Sciences
In the same journal
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 101 hits
ReferencesLink to record
Permanent link

Direct link